Affymetrix to Webcast Presentations from May Financial Conferences
May 02 2011 - 3:00PM
Business Wire
Affymetrix, Inc. (Nasdaq:AFFX) today announced that company
management will provide a corporate overview at the following
financial conferences in May.
- Deutsche Bank 2011 Healthcare
Conference, Boston, MA on Tue. May 3rd at 2:10pm ET
- Bank of America/Merrill Lynch
Healthcare Conference, Las Vegas, NV on Wed. May 11th at 1:00pm
PT
Live webcasts of all presentations will be available at
http://www.affymetrix.com under the "Investors" link. Archived
webcasts will be available for 30 days.
About Affymetrix
Affymetrix technology is used by the world's top pharmaceutical,
diagnostic, and biotechnology companies, as well as leading
academic, government, and nonprofit research institutes. More than
2,000 systems have been shipped around the world and more than
23,000 peer-reviewed papers have been published using the
technology.
Affymetrix is headquartered in Santa Clara, Calif., and has
manufacturing facilities in Santa Clara, Cleveland, Ohio, and
Singapore. The company has about 900 employees worldwide and
maintains sales and distribution operations across Europe and Asia.
For more information about Affymetrix, please visit
http://www.affymetrix.com.
Disclaimer
The information stated above was prepared by Affymetrix, Inc.
and reflects solely the opinion of Affymetrix, Inc. Nothing in this
statement shall be construed to imply any support or endorsement of
Affymetrix, Inc., or any of its products, by any other institution
mentioned, including Virginia Commonwealth University, their
officers, agents and employees.
Forward-looking statements
All statements in this press release that are not historical are
“forward-looking statements” within the meaning of Section 21E of
the Securities Exchange Act as amended, including statements
regarding Affymetrix’ “expectations,” “beliefs,” “hopes,”
“intentions,” “strategies” or the like. Such statements are subject
to risks and uncertainties that could cause actual results to
differ materially for Affymetrix from those projected. These and
other risk factors are discussed in Affymetrix’ Form 10-K for the
year ended December 31, 2009, and other SEC reports for subsequent
quarterly periods.
NOTE: Affymetrix, the Affymetrix logo, QuantiGene, and GeneChip
are trademarks or registered trademarks of Affymetrix Inc.
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Sep 2024 to Oct 2024
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Oct 2023 to Oct 2024